Pharma Pulse 11/22/24: Challenges Facing the Pharma Industry in 2025 & more

Key Challenges Facing the Pharma Industry in 2025
Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.


FDA Clears Phase II Trial of Cannabis in PTSD
After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.

Healthcare Policies to Watch in the New Trump Administration
Investors and entrepreneurs will track decisions affecting drugs, medical devices and telehealth.

Shaping the Future of Vaping
Hangsen took center stage as the headline sponsor of the UK Vaping Industry Association (UKVIA) Forum, a premier event in the vaping industry. Held at the London Marriott Hotel Regents Park, the forum brought together regulators, healthcare advocates, and industry leaders under the theme "Succeeding in a New Policy Landscape."

ConcentricLife on LinkedIn
Kudos to our ConcentricLife and Novo Nordisk teams for winning the "Believe On" campaign in the Branded Metabolic category at the 2024 Pharmaceutical Executive Apex Awards! 🎉 Your dedication and creativity made this victory possible. 🚀 #PharmaAdvertising #APEXAwards

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs